Alterations in renal interleukin-1 production during kidney transplant rejection in the rat: The effects of high-dose methyprednisolone

Roslyn B. Mannon, Syam K. Sundar, Fred P. Sanfilipro, Thomas M. Coffman

Research output: Contribution to journalArticle

Abstract

To characterize the role of interleukin-1 in renal allograft rejection, we examined the temporal relationship of IL-1 production to changes in renal function and histology in a rat kidney transplantation model. In rat renal allografts, both glomerular filtration rate and renal plasma flow (RPF) fell progressively from days 4 through 6 following transplantation. The reduction in allograft function was accompanied by histologic changes consistent with rejection and enhanced steadystate levels of IL-1β mRNA measured by Northern blot. This increase in IL-1β mRNA levels was associated with a forty-fold increase in IL-1 bioactivity in eluates of kidney allografts compared with isografts. In rejecting allografts, these changes also coincided with increased production of thromboxane Ba (TxB2) by the graft. To attempt to modify IL-1 production in the transplanted kidney, a separate group of animals with renal allografts were treated with 80 mg/kg/day of methylprednisolone for 6 days. GFR in MP-treated animals was significantly preserved compared with vehicle-treated animals. However, similar histologic manifestations of rejection were found in both groups. Although IL-1β mRNA levels in the kidney were not changed with MP treatment, renal IL-I bioactivity was reduced four-fold in animals that received MP compared with controls. Thus, IL-1β gene expression and IL-1 protein production are stimulated in rejecting kidney transplants. MP administration improves allograft function and inhibits IL-1 production, apparently at a post-transcriptional level. We hypothesize that overproduction of IL-1 during kidney transplant rejection may promote allograft dysfunction and injury. Some of the beneficial effects of corticosteroids in acute rejection may be mediated through inhibition of IL-1 release within the allograft.

Original languageEnglish (US)
Pages (from-to)1157-1162
Number of pages6
JournalTransplantation
Volume56
Issue number5
StatePublished - 1993
Externally publishedYes

Fingerprint

Graft Rejection
Interleukin-1
Allografts
Kidney
Messenger RNA
Isografts
Renal Plasma Flow
Transplants
Thromboxanes
Methylprednisolone
Glomerular Filtration Rate
Northern Blotting
Kidney Transplantation
Histology
Adrenal Cortex Hormones
Transplantation
Gene Expression

ASJC Scopus subject areas

  • Transplantation
  • Immunology

Cite this

Alterations in renal interleukin-1 production during kidney transplant rejection in the rat : The effects of high-dose methyprednisolone. / Mannon, Roslyn B.; Sundar, Syam K.; Sanfilipro, Fred P.; Coffman, Thomas M.

In: Transplantation, Vol. 56, No. 5, 1993, p. 1157-1162.

Research output: Contribution to journalArticle

Mannon, Roslyn B. ; Sundar, Syam K. ; Sanfilipro, Fred P. ; Coffman, Thomas M. / Alterations in renal interleukin-1 production during kidney transplant rejection in the rat : The effects of high-dose methyprednisolone. In: Transplantation. 1993 ; Vol. 56, No. 5. pp. 1157-1162.
@article{411994aa5a0445e58c7c2477ee32ccb9,
title = "Alterations in renal interleukin-1 production during kidney transplant rejection in the rat: The effects of high-dose methyprednisolone",
abstract = "To characterize the role of interleukin-1 in renal allograft rejection, we examined the temporal relationship of IL-1 production to changes in renal function and histology in a rat kidney transplantation model. In rat renal allografts, both glomerular filtration rate and renal plasma flow (RPF) fell progressively from days 4 through 6 following transplantation. The reduction in allograft function was accompanied by histologic changes consistent with rejection and enhanced steadystate levels of IL-1β mRNA measured by Northern blot. This increase in IL-1β mRNA levels was associated with a forty-fold increase in IL-1 bioactivity in eluates of kidney allografts compared with isografts. In rejecting allografts, these changes also coincided with increased production of thromboxane Ba (TxB2) by the graft. To attempt to modify IL-1 production in the transplanted kidney, a separate group of animals with renal allografts were treated with 80 mg/kg/day of methylprednisolone for 6 days. GFR in MP-treated animals was significantly preserved compared with vehicle-treated animals. However, similar histologic manifestations of rejection were found in both groups. Although IL-1β mRNA levels in the kidney were not changed with MP treatment, renal IL-I bioactivity was reduced four-fold in animals that received MP compared with controls. Thus, IL-1β gene expression and IL-1 protein production are stimulated in rejecting kidney transplants. MP administration improves allograft function and inhibits IL-1 production, apparently at a post-transcriptional level. We hypothesize that overproduction of IL-1 during kidney transplant rejection may promote allograft dysfunction and injury. Some of the beneficial effects of corticosteroids in acute rejection may be mediated through inhibition of IL-1 release within the allograft.",
author = "Mannon, {Roslyn B.} and Sundar, {Syam K.} and Sanfilipro, {Fred P.} and Coffman, {Thomas M.}",
year = "1993",
language = "English (US)",
volume = "56",
pages = "1157--1162",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Alterations in renal interleukin-1 production during kidney transplant rejection in the rat

T2 - The effects of high-dose methyprednisolone

AU - Mannon, Roslyn B.

AU - Sundar, Syam K.

AU - Sanfilipro, Fred P.

AU - Coffman, Thomas M.

PY - 1993

Y1 - 1993

N2 - To characterize the role of interleukin-1 in renal allograft rejection, we examined the temporal relationship of IL-1 production to changes in renal function and histology in a rat kidney transplantation model. In rat renal allografts, both glomerular filtration rate and renal plasma flow (RPF) fell progressively from days 4 through 6 following transplantation. The reduction in allograft function was accompanied by histologic changes consistent with rejection and enhanced steadystate levels of IL-1β mRNA measured by Northern blot. This increase in IL-1β mRNA levels was associated with a forty-fold increase in IL-1 bioactivity in eluates of kidney allografts compared with isografts. In rejecting allografts, these changes also coincided with increased production of thromboxane Ba (TxB2) by the graft. To attempt to modify IL-1 production in the transplanted kidney, a separate group of animals with renal allografts were treated with 80 mg/kg/day of methylprednisolone for 6 days. GFR in MP-treated animals was significantly preserved compared with vehicle-treated animals. However, similar histologic manifestations of rejection were found in both groups. Although IL-1β mRNA levels in the kidney were not changed with MP treatment, renal IL-I bioactivity was reduced four-fold in animals that received MP compared with controls. Thus, IL-1β gene expression and IL-1 protein production are stimulated in rejecting kidney transplants. MP administration improves allograft function and inhibits IL-1 production, apparently at a post-transcriptional level. We hypothesize that overproduction of IL-1 during kidney transplant rejection may promote allograft dysfunction and injury. Some of the beneficial effects of corticosteroids in acute rejection may be mediated through inhibition of IL-1 release within the allograft.

AB - To characterize the role of interleukin-1 in renal allograft rejection, we examined the temporal relationship of IL-1 production to changes in renal function and histology in a rat kidney transplantation model. In rat renal allografts, both glomerular filtration rate and renal plasma flow (RPF) fell progressively from days 4 through 6 following transplantation. The reduction in allograft function was accompanied by histologic changes consistent with rejection and enhanced steadystate levels of IL-1β mRNA measured by Northern blot. This increase in IL-1β mRNA levels was associated with a forty-fold increase in IL-1 bioactivity in eluates of kidney allografts compared with isografts. In rejecting allografts, these changes also coincided with increased production of thromboxane Ba (TxB2) by the graft. To attempt to modify IL-1 production in the transplanted kidney, a separate group of animals with renal allografts were treated with 80 mg/kg/day of methylprednisolone for 6 days. GFR in MP-treated animals was significantly preserved compared with vehicle-treated animals. However, similar histologic manifestations of rejection were found in both groups. Although IL-1β mRNA levels in the kidney were not changed with MP treatment, renal IL-I bioactivity was reduced four-fold in animals that received MP compared with controls. Thus, IL-1β gene expression and IL-1 protein production are stimulated in rejecting kidney transplants. MP administration improves allograft function and inhibits IL-1 production, apparently at a post-transcriptional level. We hypothesize that overproduction of IL-1 during kidney transplant rejection may promote allograft dysfunction and injury. Some of the beneficial effects of corticosteroids in acute rejection may be mediated through inhibition of IL-1 release within the allograft.

UR - http://www.scopus.com/inward/record.url?scp=0027427116&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027427116&partnerID=8YFLogxK

M3 - Article

C2 - 8249118

AN - SCOPUS:0027427116

VL - 56

SP - 1157

EP - 1162

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 5

ER -